Susquehanna International Group, LLP Champions Oncology, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 33,930 shares of CSBR stock, worth $221,562. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,930
Previous 126,530
73.18%
Holding current value
$221,562
Previous $1.1 Million
77.23%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CSBR
# of Institutions
35Shares Held
5.81MCall Options Held
35.4KPut Options Held
0-
Battery Management Corp. Boston, MA2.42MShares$15.8 Million3.14% of portfolio
-
Nea Management Company, LLC Timonium, MD1.71MShares$11.2 Million1.05% of portfolio
-
Tocqueville Asset Management L.P. New York, NY400KShares$2.61 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA327KShares$2.14 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny181KShares$1.18 Million0.0% of portfolio
About CHAMPIONS ONCOLOGY, INC.
- Ticker CSBR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,522,400
- Market Cap $88.3M
- Description
- Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...